-
公开(公告)号:US10189074B2
公开(公告)日:2019-01-29
申请号:US15547749
申请日:2016-03-04
Applicant: Cambridge Enterprise Limited
Inventor: Julian Allwood , Christopher Cleaver
Abstract: A ring rolling process and corresponding apparatus are disclosed. A ring shaped workpiece is provided, the ring shaped workpiece having a principal axis, an inner radial surface, an outer radial surface, a first axial surface and a second axial surface. The workpiece is subjected to radial pressure between a forming roll 150a acting on the outer radial surface and a mandrel roll 152a, 152b acting on the inner radial surface, at a radial roll bite region. A first axial roll 154a and a second axial roll 156a are provided at the first axial surface and the second axial surface respectively, to subject the workpiece to axial pressure. The first and second axial rolls 154a, 156a are provided at an angular position, measured around the workpiece and with respect to the principal axis, within ±10° of said radial roll bite region. Multiple circumferential constraint rolls are provided around the outer radial surface or inner radial surface. In order to control the cross sectional shape of the workpiece, the mandrel roll 152a, 152b and/or the forming roll 150a has a projecting portion for contact with the workpiece, the projecting portion having an axial extent which is smaller than the axial height of the workpiece, the mandrel roll and/or forming roll being axially moveable relative to the workpiece.
-
公开(公告)号:US20180327869A1
公开(公告)日:2018-11-15
申请号:US15525803
申请日:2015-11-12
Applicant: CAMBRIDGE ENTERPRISE LIMITED
Inventor: Bryn Hardwick
IPC: C12Q1/6897 , G01N33/50
CPC classification number: C12Q1/6897 , G01N33/5041 , C12Q2563/107
Abstract: A method for the identification of new therapeutic targets and protein interaction sites for use in drug discovery. In particular the invention relates to a method for identifying inhibitors of a cell signalling pathway, the method comprising (1) providing a population of mammalian cells, each mammalian cell having an active cell signalling pathway and comprising: (a) a first heterologous nucleic acid comprising; (i) a nucleotide sequence encoding a first detectable reporter and, (ii) a constitutive regulatory element which is operably linked to the nucleotide sequence; and, (b) a second heterologous nucleic acid comprising: (i) a first nucleotide sequence encoding a repressor molecule, for example an RNA or protein, which inactivates, inhibits or suppresses expression of the first detectable reporter, (ii) a second nucleotide sequence encoding a second detectable reporter; and (iii) a signal-activated regulatory element which is activated by said cell signalling pathway, said signal-activated regulatory element being operably linked to the first and second nucleotide sequences, (2) introducing a library of test compounds into said population of mammalian cells, and; (3) determining the expression of the first and the second detectable reporters in one or more of the population of transfected cells, wherein expression of the first detectable reporter but not the second detectable reporter in a transfected cell is indicative that the test biomolecule expressed by the nucleic acid in the cell inhibits said cell signalling pathway.
-
公开(公告)号:US10088482B2
公开(公告)日:2018-10-02
申请号:US15288934
申请日:2016-10-07
Applicant: Cambridge Enterprise Limited , Medical Research Council
Inventor: Christopher J. Peters , Carlos Caldas , Rebecca C. Fitzgerald
IPC: G01N33/574
Abstract: The present invention relates to a method of aiding in the prognosis of a subject with oesophageal and/or gastro-oesophageal junctional (GOJ) adenocarcinoma, the method comprising the steps of: (a) providing a sample from the subject, (b) determining the expression level of biomarkers TRIM44 and SIRT2 in said sample, and either (i) determining the expression level of biomarker PAPPS2 in said sample; or (ii) determining the expression level of biomarkers WT1 and EGFR in said sample; (c) comparing the expression level of each of said biomarkers to a corresponding reference standard, (d) determining the biomarkers of (b) whose expression is dysregulated compared to the reference standard, (e) inferring from the dysregulated biomarkers identified in (d) the prognosis of 5-year survival, wherein the greater the number of said biomarkers which are dysregulated, the greater the reduction in prognosis of 5-year survival. The invention also relates to kits, uses and devices.
-
公开(公告)号:US20180198384A1
公开(公告)日:2018-07-12
申请号:US15744344
申请日:2016-07-15
Applicant: Cambridge Enterprise Limited
Inventor: Yu JIA , Ashwin Arunkumar SESHIA , Sijun DU
IPC: H02N2/18 , H01L41/047 , H01L41/08 , H01L41/113
CPC classification number: H02N2/188 , H01L41/0478 , H01L41/081 , H01L41/1136 , H01L41/1138
Abstract: An apparatus is provided for harvesting energy from mechanical vibrations with an improved power output. The apparatus comprises a frame (22), a first member (20) comprising a piezoelectric material, a cantilever beam (26) and an electrode. The first member is fixed to the frame at a first position and a second position and extends between the first and second positions. The cantilever beam has a first end fixed to the first member between the first position and the second position and a second end fixed to a proof mass (24). The electrode is fixed to the first member at a position between the first position and the second position. In another aspect, the apparatus may comprise a plurality of proof masses connected to the first member between the first and second positions in a spaced relationship to one another.
-
公开(公告)号:US20180183122A1
公开(公告)日:2018-06-28
申请号:US15736195
申请日:2016-05-20
Applicant: Cambridge Enterprise Limited
Inventor: Clare Grey , Tao Liu , Wanjing Yu
CPC classification number: H01M12/08 , H01M4/382 , H01M4/388 , H01M4/48 , H01M4/8605 , H01M4/8615 , H01M4/90 , H01M4/9016 , H01M4/96 , H01M2300/0017 , H01M2300/0028 , Y02E60/128
Abstract: The invention provides a method for discharging and/or charging a lithium-oxygen battery, where the method comprises the steps of (i) generating a discharge product on or within a working electrode in a lithium-oxygen battery in a discharging step, wherein the amount of LiOH in the discharge product is greater than the amount of Li2O2; and/or (ii) consuming LiOH on or within a working electrode in a lithium-oxygen battery in a charging step, thereby to generate oxygen optionally together with water, wherein the amount of LiOH consumed in the charging step is greater than the amount of Li2O2 consumed. The the lithium-oxygen battery has an electrolyte comprising an organic solvent, and optionally the water content of the electrolyte after a charging step is 0.01 wt % or more.
-
公开(公告)号:US09994636B2
公开(公告)日:2018-06-12
申请号:US15232259
申请日:2016-08-09
Applicant: MEDIMMUNE LIMITED , CAMBRIDGE ENTERPRISE LIMITED
Inventor: John Elvin , Catherine Huntington , John Trowsdale , Alexander Barrow , Huan Cao
CPC classification number: C07K16/2803 , C07K16/30 , C07K2317/33 , C07K2317/56 , C07K2317/565 , C07K2317/77
Abstract: This disclosure relates to anti-Siglec-15 antibodies and uses thereof, in particular in the treatment of leukaemia, such as acute myeloid leukaemia.
-
公开(公告)号:US20180140417A1
公开(公告)日:2018-05-24
申请号:US15572750
申请日:2016-05-11
Applicant: CAMBRIDGE ENTERPRISE LIMITED
Inventor: Paolo De SCISCIO , Jacob BRUBERT
CPC classification number: A61F2/2418 , A61F2/04 , A61F2/2412 , A61F2/82 , A61F2002/047
Abstract: An implant device for insertion in a human or animal body comprises a frame, wherein at least a portion of the frame is capable of reversibly transitioning between a solid state rigid mode and a liquid state flexible mode, thereby allowing the device to change its shape.
-
公开(公告)号:US09958369B2
公开(公告)日:2018-05-01
申请号:US14438145
申请日:2013-10-22
Applicant: CAMBRIDGE ENTERPRISE LIMITED
Inventor: Samuel Cohen , Tuomas Knowles , Christopher Dobson , Luke Rajah , Duncan White
IPC: G01N13/00 , B01F5/04 , B01F5/06 , B01F13/00 , G01N33/487
CPC classification number: G01N13/00 , B01F5/045 , B01F5/0647 , B01F13/0093 , G01N33/487 , G01N2013/003
Abstract: A method for determining the diffusion of one or more components, the method includes the steps of (i) providing a component fluid flow having one or more components; (ii) providing a blank fluid flow; (iii) bringing the flow (i) into contact with the flow (ii) in a large cross section channel, thereby to generate two laminar flows; (iv) permitting the laminar flows generated in (iii) to flow from the large cross section channel into a small cross section channel; measuring the lateral diffusion of the one or more components from the component flow into the blank fluid flow in the small cross section channel. Also provided is a diffusion method having the steps of measuring the lateral diffusion of the one or more components from the component flow into the blank fluid flow at a plurality of diffusion times.
-
公开(公告)号:US09930431B2
公开(公告)日:2018-03-27
申请号:US15174954
申请日:2016-06-06
Applicant: Cambridge Enterprise Limited
Inventor: Daping Chu , Neil Collings , William Crossland , Maura Michelle Redmond , Brian Robertson
CPC classification number: H04Q11/0005 , G02F1/292 , G02F2203/12 , G02F2203/18 , G03H1/0005 , G03H1/2294 , G03H2225/32 , H04J14/0212 , H04L45/62 , H04Q2011/0016
Abstract: This invention relates to methods and apparatus for routing light beams in telecommunications devices using holographic techniques, in particular by displaying kinoforms on Liquid Crystal on Silicon devices. At least one optical input to receives an input beam. A plurality of optical outputs and a spatial light modulator (SLM) on an optical path between said optical input and said optical outputs are provided, and a driver for said SLM to display a kinoform on said SLM diffracts said input beam into an output beam comprising a plurality of diffraction orders, wherein a routed one of said diffraction orders is directed to at least one selected said optical output; said apparatus is configured to modify a wavefront of said output beam to reduce a coupling of said output beam into said selected optical output; and said kinoform is adapted to compensate for said wavefront modification to compensate for said reduced coupling.
-
公开(公告)号:US09882130B2
公开(公告)日:2018-01-30
申请号:US14700944
申请日:2015-04-30
Applicant: Cambridge Enterprise Limited , Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung E.V.
Inventor: Hans-Frieder Schleiermacher , Birger Zimmerman , Michael Niggemann
IPC: H01L51/00 , H01L21/311 , H01L21/3213 , B82Y10/00 , H01L31/18 , C23F1/02 , C23F1/00 , B05C5/02 , B05C11/02 , H01L51/42
CPC classification number: H01L51/0017 , B05C5/0216 , B05C11/026 , B82Y10/00 , C23F1/00 , C23F1/02 , H01L21/31111 , H01L21/32134 , H01L31/18 , H01L51/0007 , H01L51/0019 , H01L51/0036 , H01L51/0037 , H01L51/0047 , H01L51/4253
Abstract: An apparatus for patterning an article that comprises a first layer of a first material. The apparatus includes a thread, at least one thread guide for guiding the thread such that at least a portion of the thread engages with the article, a unit for moving the thread relative to the at least one thread guide means, and a unit for applying a solvent to the thread before the thread contacts the article, wherein the first material is soluble in the solvent.
-
-
-
-
-
-
-
-
-